|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's range||365.61 - 375.00|
|52-week range||253.86 - 475.35|
|Beta (5Y monthly)||0.97|
|PE ratio (TTM)||46.16|
|Earnings date||16 Feb 2022 - 21 Feb 2022|
|Forward dividend & yield||0.72 (0.19%)|
|Ex-dividend date||18 Jan 2022|
|1y target est||457.00|
It is hard to get excited after looking at West Pharmaceutical Services' (NYSE:WST) recent performance, when its stock...
Quest Diagnostics (DGX) continues to benefit from rapidly increasing molecular diagnostic testing volumes, driven by the massive spread of the new COVID-19 variant.
Investors are optimistic about Hologic (HOLX) given the strength in the diagnostics business and notable acquisition deals.